Plexa ICD Lead Registry

NCT ID: NCT03103503

Last Updated: 2020-10-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

901 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-18

Study Completion Date

2019-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this registry is to confirm the long-term safety and reliability of BIOTRONIK's Plexa ICD lead.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implantable Defibrillator User

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Successfully implanted with a BIOTRONIK ICD or CRT-D compatible system along with the Plexa lead no more than 30 days prior to consent
* Able to understand the nature of the registry and provide informed consent
* Available for follow-up visits on a regular basis at the study site for the expected 5 years of follow-up
* Accepts BIOTRONIK Home Monitoring® concept
* Age greater than or equal to 18 years

Exclusion Criteria

* Enrolled in any investigational cardiac device trial
* Enrolled in BIOTRONIK's QP ExCELs lead study
* Planned cardiac surgical procedures or interventional measures within the next 6 months
* Expected to receive heart transplantation or ventricular assist device within 1 year
* Life expectancy of less than 1 year
* Patients reporting pregnancy at the time of enrollment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biotronik, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Thomas Hospital Research Office

Fairhope, Alabama, United States

Site Status

Jeffrey S Goodman MD

Los Angeles, California, United States

Site Status

Eisenhower Desert Cardiology

Rancho Mirage, California, United States

Site Status

Florida Hospital

Orlando, Florida, United States

Site Status

Advent Health Tampa

Tampa, Florida, United States

Site Status

St. Louis Cardiology Consultants

Alton, Illinois, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

Heartland Cardiology

Wichita, Kansas, United States

Site Status

Research Integrity LLC

Owensboro, Kentucky, United States

Site Status

Northern Light Cardiology

Bangor, Maine, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Metro Health Hospital

Wyoming, Michigan, United States

Site Status

Michigan Heart

Ypsilanti, Michigan, United States

Site Status

Mercy Clinic Cardiology

Springfield, Missouri, United States

Site Status

St. Louis Heart and Vascular

St Louis, Missouri, United States

Site Status

Gateway Cardiovascular Research Center

St Louis, Missouri, United States

Site Status

Mercy Clinic Heart and Vascular

St Louis, Missouri, United States

Site Status

Glacier View Research Institute Cardiology

Kalispell, Montana, United States

Site Status

Deborah Heart and Lung Center

Browns Mills, New Jersey, United States

Site Status

Novant Health

Winston-Salem, North Carolina, United States

Site Status

Sanford Medical Center

Fargo, North Dakota, United States

Site Status

The Ohio State Wexner Medical Center

Columbus, Ohio, United States

Site Status

Toledo Cardiology

Toledo, Ohio, United States

Site Status

The Arrhythmia Institute

Newtown, Pennsylvania, United States

Site Status

Upstate Cardiology

Greenville, South Carolina, United States

Site Status

Carolina Heart Specialists

Lancaster, South Carolina, United States

Site Status

Carolina Cardiology Associates

Rock Hill, South Carolina, United States

Site Status

Cardiovascular Associates Ltd

Virginia Beach, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Plexa Registry

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lumax DX / Linox DX Evaluation
NCT01486836 COMPLETED
Lead Extract Study
NCT01169441 COMPLETED
Lead Registry for Optim Leads
NCT01722188 COMPLETED
Linox Smart S DX PME/Master Study
NCT01090401 COMPLETED PHASE4